Abstract

Despite intense interest and considerable effort via high-throughput screening, there are few examples of small molecules that directly inhibit protein-protein interactions. This suggests that many protein interaction surfaces may not be intrinsically “druggable” by small molecules, and elevates in importance the few successful examples as model systems for improving our fundamental understanding of druggability. Here we describe an approach for exploring protein fluctuations enriched in conformations containing surface pockets suitable for small molecule binding. Starting from a set of seven unbound protein structures, we find that the presence of low-energy pocket-containing conformations is indeed a signature of druggable protein interaction sites and that analogous surface pockets are not formed elsewhere on the protein. We further find that ensembles of conformations generated with this biased approach structurally resemble known inhibitor-bound structures more closely than equivalent ensembles of unbiased conformations. Collectively these results suggest that “druggability” is a property encoded on a protein surface through its propensity to form pockets, and inspire a model in which the crude features of the predisposed pocket(s) restrict the range of complementary ligands; additional smaller conformational changes then respond to details of a particular ligand. We anticipate that the insights described here will prove useful in selecting protein targets for therapeutic intervention.

Highlights

  • Manipulating the interactions between proteins represents a promising avenue for therapeutic intervention in a variety of settings

  • Identifying small-molecule inhibitors of protein interactions has traditionally presented a challenge for modern screening methods, despite interest stemming from the fact that such interactions comprise the underlying mechanisms for cell proliferation, differentiation, and survival

  • This suggests that many protein interaction surfaces may not be intrinsically ‘‘druggable’’ by small molecules, and elevates in importance the few successful examples as model systems for improving our understanding of factors contributing to druggability

Read more

Summary

Introduction

Manipulating the interactions between proteins represents a promising avenue for therapeutic intervention in a variety of settings. While high-throughput screening efforts that fail to yield extensive hits are typically not reported in the literature, hit rates as low as 0.01% in a large pharmaceutical library have been described [13]. This dearth of successful representatives to study has given increased importance to the several cases in which a protein structure has been solved in complex with a biological protein partner and in complex with a small molecule inhibitor. In order for inhibitor binding to occur, the surface of the unbound structure had to undergo local rearrangement to reveal a small molecule binding site that would not necessarily be evident from the unbound structure [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call